Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs SANOFI INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA SANOFI INDIA AJANTA PHARMA/
SANOFI INDIA
 
P/E (TTM) x 23.7 22.5 105.5% View Chart
P/BV x 4.9 6.0 81.3% View Chart
Dividend Yield % 0.8 8.6 8.8%  

Financials

 AJANTA PHARMA   SANOFI INDIA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-22
SANOFI INDIA
Dec-21
AJANTA PHARMA/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1,6149,300 17.4%   
Low Rs1,0897,344 14.8%   
Sales per share (Unadj.) Rs391.11,283.8 30.5%  
Earnings per share (Unadj.) Rs83.4410.1 20.3%  
Cash flow per share (Unadj.) Rs98.1439.0 22.3%  
Dividends per share (Unadj.) Rs9.50490.00 1.9%  
Avg Dividend yield %0.75.9 11.9%  
Book value per share (Unadj.) Rs382.1940.3 40.6%  
Shares outstanding (eoy) m85.4223.03 370.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.56.5 53.3%   
Avg P/E ratio x16.220.3 79.8%  
P/CF ratio (eoy) x13.819.0 72.7%  
Price / Book Value ratio x3.58.9 40.0%  
Dividend payout %11.4119.5 9.5%   
Avg Mkt Cap Rs m115,433191,661 60.2%   
No. of employees `000NANA-   
Total wages/salary Rs m6,4584,339 148.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m33,41029,566 113.0%  
Other income Rs m1,157746 155.1%   
Total revenues Rs m34,56730,312 114.0%   
Gross profit Rs m9,29312,515 74.3%  
Depreciation Rs m1,253667 187.8%   
Interest Rs m10218 566.7%   
Profit before tax Rs m9,09512,576 72.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,9683,132 62.8%   
Profit after tax Rs m7,1279,444 75.5%  
Gross profit margin %27.842.3 65.7%  
Effective tax rate %21.624.9 86.9%   
Net profit margin %21.331.9 66.8%  
BALANCE SHEET DATA
Current assets Rs m24,54836,791 66.7%   
Current liabilities Rs m8,37722,908 36.6%   
Net working cap to sales %48.447.0 103.1%  
Current ratio x2.91.6 182.5%  
Inventory Days Days42189 22.2%  
Debtors Days Days1118 63.2%  
Net fixed assets Rs m19,25918,762 102.6%   
Share capital Rs m172230 74.7%   
"Free" reserves Rs m32,46921,425 151.5%   
Net worth Rs m32,64021,655 150.7%   
Long term debt Rs m160-   
Total assets Rs m43,80755,553 78.9%  
Interest coverage x90.2699.7 12.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.5 143.3%   
Return on assets %16.517.0 96.9%  
Return on equity %21.843.6 50.1%  
Return on capital %28.258.2 48.4%  
Exports to sales %00-   
Imports to sales %019.4 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA5,723 0.0%   
Fx inflow Rs m18,6783,856 484.4%   
Fx outflow Rs m3,6625,723 64.0%   
Net fx Rs m15,016-1,867 -804.3%   
CASH FLOW
From Operations Rs m5,6205,588 100.6%  
From Investments Rs m-7416,308 -11.7%  
From Financial Activity Rs m-4,600-8,490 54.2%  
Net Cashflow Rs m2793,406 8.2%  

Share Holding

Indian Promoters % 70.5 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 21.4 26.5 80.5%  
FIIs % 8.2 8.3 99.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.5 39.6 74.5%  
Shareholders   62,048 73,734 84.2%  
Pledged promoter(s) holding % 17.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs Sanofi India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs Sanofi India Share Price Performance

Period AJANTA PHARMA Sanofi India S&P BSE HEALTHCARE
1-Day 1.29% -0.42% 0.23%
1-Month -4.86% 1.76% 0.36%
1-Year -9.96% -29.47% -6.87%
3-Year CAGR 23.29% -6.79% 20.16%
5-Year CAGR 6.17% 5.23% 11.07%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the Sanofi India share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 70.5% stake in the company. In case of Sanofi India the stake stands at 60.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of Sanofi India.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 9.5 per share. This amounted to a Dividend Payout ratio of 11.4%.

Sanofi India paid Rs 490.0, and its dividend payout ratio stood at 119.5%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of Sanofi India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Mark Mobius on Cryptos | Dharmaj Crop IPO Fully Subscribed on Debut | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets hit new records following heavy gains from Reliance and other oil marketing companies as crude prices fell.